Up to 15pc hike in prices of medicines, 9pc for life-saving drugs approved

Published January 11, 2019
The drug manufacturing companies had been demanding 40pc increase in medicines' prices. — AFP/File
The drug manufacturing companies had been demanding 40pc increase in medicines' prices. — AFP/File

The Drug Regulatory Authority of Pakistan (Drap) on Friday, with the approval of the federal government, announced up to 15 per cent hike in the prices of medicines, apart from life-saving drugs.

Notification for increase in price of medicines.
Notification for increase in price of medicines.

According to a notification by Drap, available with DawnNewsTV, nine per cent hike has been approved in the prices of life-saving drugs, whereas a 15pc hike was approved in the prices of all other medicines.

"The revised maximum retail prices shall be printed on the label in the manner prescribed by the Drugs [Labelling and Packaging] Rules, 1986 and the manufacturers and importers of drugs shall furnish calculations of revised maximum retail price of drugs to the Division of Costing and Pricing of the Drug Regulatory Authority of Pakistan before affecting the increase," adds the notification.

The Pakistan Pharmaceutical Manufacturers Association (PPMA) Chairperson Zahid Saeed said that the drug manufacturing companies have been demanding 40pc increase in the prices of medicines.

He said that the increase was inevitable because of the increase in dollar's value, adding that PPMA was reviewing the contents of the notification.

Last year, a three-judge Supreme Court bench had taken up a suo motu notice about the increase in prices of drugs. In August, Chief Justice of Pakistan Mian Saqib Nisar had directed Drap to decide within 10 weeks all pending cases of pharmaceutical companies regarding medicine prices.

He had said the existing prices of all medicines would remain frozen till a decision on the cases. While rejecting a petition moved by one of the drug importers challenging the Drap policy, he observed that the court had no jurisdiction to interfere in policy matters of the government.

Follow Dawn Business on Twitter, LinkedIn, Instagram and Facebook for insights on business, finance and tech from Pakistan and across the world.

Opinion

Editorial

Kurram atrocity
Updated 22 Nov, 2024

Kurram atrocity

It would be a monumental mistake for the state to continue ignoring the violence in Kurram.
Persistent grip
22 Nov, 2024

Persistent grip

An audit of polio funds at federal and provincial levels is sorely needed, with obstacles hindering eradication efforts targeted.
Green transport
22 Nov, 2024

Green transport

THE government has taken a commendable step by announcing a New Energy Vehicle policy aiming to ensure that by 2030,...
Military option
Updated 21 Nov, 2024

Military option

While restoring peace is essential, addressing Balochistan’s socioeconomic deprivation is equally important.
HIV/AIDS disaster
21 Nov, 2024

HIV/AIDS disaster

A TORTUROUS sense of déjà vu is attached to the latest health fiasco at Multan’s Nishtar Hospital. The largest...
Dubious pardon
21 Nov, 2024

Dubious pardon

IT is disturbing how a crime as grave as custodial death has culminated in an out-of-court ‘settlement’. The...